BMRN

BIOMARIN PHARMACEUTICAL INC

Healthcare | Large Cap

$1.10

EPS Forecast

$793.3

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$1.10

Revenue Forecast:

$793.3

EPS Surprise Forecast:

$0.124

Revenue Surprise Forecast:

$13

Post-release price volatility - Medium

Post-release Overnight Move:

±6.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

84%

Probability of beating revenue consensus:

77%

Probability of beating both EPS & revs consensus:

68%

Probability of missing both EPS & revs consensus:

8%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

1

Beta (β)

Forward Looking Beta (β):

0.57

Earnings volatility

EPS standard deviation:

$0.28

Revenue standard deviation:

$37

As % of share price:

0.51% HIGH

As % of market cap:

0.35% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$1.48

Revenue 95th %ile:

$845

EPS 75th %ile:

$1.20

Revenue 75th %ile:

$807

EPS 25th %ile:

$1.02

Revenue 25th %ile:

$781

EPS 5th %ile:

$0.81

Revenue 5th %ile:

$751

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

65% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$9

Bid-ask per Share:

$0.05